Call for Abstract
2nd International Conference on Vaccine Research, will be organized around the theme “Recent Advancements in Vaccination & Antibiotics Application ”
European Vaccine 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in European Vaccine 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Nowadays vaccination may be an important a part of public health and family. Vaccines work to prime your system against future “attacks” by a selected malady. It conjointly makes the system bear in mind these foreign agents. It helps to fight against several chronic and contagious diseases like poliomyelitis, mumps, HIV, HPV, small pox, cancer, Influenza, etc. The traditional vaccine consists of agents that resemble the disease-causing organism. When these agents enter the human body they stimulate the immune system to recognize these agents as foreign and destroy them. It also makes the immune system remember these foreign agents so that they can recognize and destroy the real live virulent germs. A vaccine can be administered into the body through injections, by mouth or by aerosol.
- Track 1-1Diphtheria Vaccine
- Track 1-2Plague and Tularemia
- Track 1-3Ebola, Marburg, Lassa, and Machupo Virus
- Track 1-4Q fever, Ricin toxin, Typhus fever
- Track 1-5Nipah virus
Vaccination is more important in our life for keeping us healthy.Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated.Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available.These combine the discovery of novel antigens, adjuvants, and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Each novel vaccine candidate needs to be evaluated for safety, immunogenicity, and protective efficacy in humans before it is licensed.
- Track 2-1Current Challenges in vaccine R & DCurrent Focus on medicine analysis
- Track 2-2Regulatory and Economic Aspects in medicine
- Track 2-3Viral genetic science and genetics
- Track 2-4Viral genetic science and genetics
Plant-based vaccine technologies involve the integration of the desired genes encoding the antigen protein for specific disease into the genome of plant tissues by various methods. However, advancements in the field of science and technology developed new approaches such as agroinfiltration, electroporation, polyethene glycol treatment and sonication to replace the former methods. The mucosal immunity and systemic immunity are highly conferred by plant made antigens through oral vaccination.
The major goals of veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA. Trials are underway for the oral immunization of dogs in developing countries.
- Track 3-1Equine Vaccination
- Track 3-2Agro infiltration and Magnification
- Track 3-3Modified live-virus veterinary vaccines for oral immunization of wildlife
- Track 3-4Highly immunogenic inactivated cell culture vaccines
- Track 3-5Vaccines for parenteral use
Basically three types of vaccination strategies are used to give vaccines such as pulse vaccination strategy (repeatedly vaccinating over a defined age range), ring vaccination (vaccinating only those who are most likely to be infected) and cocooning (giving booster vaccines to mothers, family members to protect new-born babies from becoming infected by them). Immunizations can anticipate or enhance irresistible ailment. Immunization is the procedure whereby a man is made safe or impervious to an irresistible sickness, ordinarily by the organization of an antibody. The main ability of the vaccines is to induce the humoral antibody responses and cell mediated responses against the wide range of pathogens.
- Track 4-1Vaccine Sustainability
- Track 4-2Immunity electromagnetic interference
- Track 4-3Vaccine storage and related errors
- Track 4-4Designing Vaccines in the Era of Genomics
- Track 4-5Vaccine Safety Programs
Immunization safety is a wide subject area, ranging from vaccine manufacturing and regulation to the point of use of vaccine at immunization sessions, and includes the disposal of used equipment. So far in the modern generation, the development of vaccines against malaria, tuberculosis, and HIV has become a challenging entity. Vaccines are developed in accordance with the highest standards of safety because vaccines must be safe for use by as many people as possible. Each individual has a unique identity response to vaccines, and there is no way to absolutely guess the reaction of a specific individual to a particular vaccine. Vaccination is the most secure and best general successfulness equipment accessible for counteracting illness and death. Adequate immunizations ensure people whenever regulated before introduction.
- Track 5-1Vaccine Schedule and Administration
- Track 5-2Adverse vaccine incident
- Track 5-3Vaccination to Global Health
- Track 5-4Cost-effectiveness analyses and evaluation
Vaccine adjuvants – is an ingredient of a vaccine that helps to create a stronger immune response in the patient’s body. In other words, adjuvants help vaccines work better. Few vaccines are made from weak or dead germs which contain natural adjuvants and help the body to produce a protective immune response. The amount of aluminium present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA). Medicinal adjuvants are added to antibodies for a reaction in a secure framework to the target substance; nevertheless, do not offer of being influenced.
- Track 6-1Simulating Immune Systems
- Track 6-2Mechanism of Adjuvants
- Track 6-3Organic Adjuvants
- Track 6-4Immunologic Adjuvants
Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine the discovery of novel antigens, adjuvants, and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines, and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.
- Track 7-1Antigen discovery
- Track 7-2Immunological challenges
- Track 7-3Aspects of pathology and host responses
- Track 7-4Expanded testing and modelling of vaccine
- Track 7-5Chloroplast-derived vaccines antigens and therapeutics
Vaccination is the most important approach to counteract infectious diseases. Thus, the development of new and improved vaccines for existing, emerging, and re-emerging diseases is an area of great interest to the scientific community and the general public. The recent advancements in vaccines defend the folks from the wide range of diseases. The most ability of the vaccines is to induce the body substance protein responses and cell-mediated responses against the big selection of pathogens. To boot, the invention is accustomed to turning out the vaccines, immunogens and valuable therapeutic and diagnostic reagents. Among the tools available for disease prevention and control, vaccines rank high with respect to effectiveness and economic feasibility. Vaccine manufacture is one of the most challenging industries. Manufacturing an anti-virus vaccine today is a complicated process even after the hard task of creating a potential vaccine in the laboratory. There are different vaccine production technologies approved by the U.S. Food and Drug Administration (FDA): egg-based flu vaccine, cell-based flu vaccine, and recombinant flu vaccine• Track 13-1Modular approaches to vaccine production.
- Track 8-1Vaccines Formulation
- Track 8-2Cross-flow filtration
- Track 8-3Increasing vaccine stability
- Track 8-4Ultracentrifugation operations
Vaccines are prepared to provide the protection against different kinds of viral diseases like hepatitis, viral cancer, MMR, poliomyelitis, influenza etc., different kinds of bacterial diseases like anthrax, diphtheria, tetanus, tuberculosis, typhoid, cholera and many more. Nowadays parasitic malarial vaccines and non-infectious disease vaccines like DNA vaccines for preventing tumor and allergy are also available. These molecular preparations play very important role to boost the immune system.
- Track 9-1Live, Attenuated Vaccines
- Track 9-2Killed or Inactivated Vaccines
- Track 9-3Toxoids
- Track 9-4Subunit and Conjugate Vaccines
Vaccination plays an important role for both maternal and neonatal health conditions. It is so beneficial for women to be immunized to reduce chances of morbidity and mortality from vaccine-preventable diseases. Some vaccines should be given to mother before pregnancy, some during pregnancy and some post pregnancy. Neonatal vaccination is the lifetime opportunity to initiate the early protective response against infectious diseases like polio, smallpox etc.
- Track 10-1Pregnancy & MMR Vaccines
- Track 10-2Neonatal respiratory syncytial virus infection vaccine
- Track 10-3Severe reactions to foods, insect stings, and medications (anaphylaxis)
- Track 10-4Pneumococcal or Pneumo Jab (PCV) vaccines
- Track 10-5Rotavirus vaccines
Cancer vaccines can treat existing cancer (therapeutic cancer vaccines) and prevent development of cancers. Some vaccines are autologous or patient specific. Many cancers are caused by oncoviruses like HPV, hepatitis B and also by oncobacteria like Helicobacter pylori. Nowadays, approved oncovaccines like oncophage, Sipuleucel-T are used in many countries for cancer immunotherapy.
Basically three types of vaccination strategies are used to give vaccines such as pulse vaccination strategy (repeatedly vaccinating over a defined age range), ring vaccination (vaccinating only those who are most likely to be infected) and cocooning (giving booster vaccines to mothers, family members to protect new-born babies becoming infected by them).
Vaccine trial or clinical trials are required for the safety and efficacy of the vaccines. Four different phases of trials are present in trial methodology as phase one, phase two, phase three and phase four.
Different types of viral, bacterial, parasitic and non-infectious disease vaccines are under research at present time like zika, adenovirus, hepatitis c, leprosy, chagas disease, Alzheimer’s disease and so on.
Antibiotics are the most important antimicrobial agents for fighting against bacterial, fungal activities or infections. Three types of antibiotics are found as natural antibiotics which are produced by natural microorganisms via fermentation, semi-synthetic antibiotics that can be prepared by using natural fermentation process with chemical combination and synthetic antibiotics which are completely prepared in laboratory synthetically.
The resistance of bacteria or microbes to antibiotics is very common phenomenon. Though survival of microbe results from an inheritable resistance but the growth of resistance to antibiotics also occurs through horizontal gene transfer, which is more likely to occur for frequent antibiotic use. Antibacterial-resistant strains and species are called superbugs in some cases like E. coli bacteria superbug, multidrug-resistant tuberculosis.
Due to antimicrobial resistance phenomenon, some infectious microbes become untreatable. Various efforts have been made to develop the next generation antibiotics with novel action mechanisms which can combat against the multi-drug resistant strains of microbes. Recently, symbiotic bacteria are also used to produce antibiotics against MDR strains like odilorhabdins (ODLs).